Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$45.46 - $50.51 $1.41 Million - $1.57 Million
-30,984 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$45.3 - $51.62 $3.08 Million - $3.5 Million
-67,884 Reduced 68.66%
30,984 $1.51 Million
Q3 2020

Nov 12, 2020

SELL
$49.47 - $53.77 $35,766 - $38,875
-723 Reduced 0.73%
98,868 $4.96 Million
Q2 2020

Aug 12, 2020

SELL
$42.91 - $52.5 $1.31 Million - $1.6 Million
-30,455 Reduced 23.42%
99,591 $5.08 Million
Q1 2020

May 13, 2020

SELL
$38.02 - $51.66 $90,259 - $122,640
-2,374 Reduced 1.79%
130,046 $5.69 Million
Q4 2019

Feb 11, 2020

SELL
$44.25 - $50.86 $998,014 - $1.15 Million
-22,554 Reduced 14.55%
132,420 $6.65 Million
Q3 2019

Nov 12, 2019

BUY
$40.34 - $46.64 $19,161 - $22,154
475 Added 0.31%
154,974 $7.18 Million
Q2 2019

Aug 08, 2019

SELL
$40.43 - $44.3 $55,995 - $61,355
-1,385 Reduced 0.89%
154,499 $6.69 Million
Q1 2019

May 13, 2019

BUY
$40.83 - $45.43 $25,192 - $28,030
617 Added 0.4%
155,884 $6.9 Million
Q4 2018

Feb 12, 2019

BUY
$41.48 - $45.59 $353,741 - $388,791
8,528 Added 5.81%
155,267 $6.74 Million
Q3 2018

Nov 08, 2018

SELL
$40.0 - $44.84 $70,000 - $78,470
-1,750 Reduced 1.18%
146,739 $6.56 Million
Q2 2018

Aug 02, 2018

BUY
$37.63 - $41.22 $619,540 - $678,646
16,464 Added 12.47%
148,489 $5.94 Million
Q1 2018

May 10, 2018

SELL
$38.98 - $45.76 $860,444 - $1.01 Million
-22,074 Reduced 14.32%
132,025 $5.29 Million
Q4 2017

Feb 02, 2018

SELL
$42.86 - $50.61 $28,887 - $34,111
-674 Reduced 0.44%
154,099 $6.63 Million
Q3 2017

Oct 25, 2017

BUY
$47.04 - $50.34 $7.28 Million - $7.79 Million
154,773
154,773 $7.71 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $137B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Heartland Advisors Inc Portfolio

Follow Heartland Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.